JP2025507543A5 - - Google Patents
Info
- Publication number
- JP2025507543A5 JP2025507543A5 JP2024547297A JP2024547297A JP2025507543A5 JP 2025507543 A5 JP2025507543 A5 JP 2025507543A5 JP 2024547297 A JP2024547297 A JP 2024547297A JP 2024547297 A JP2024547297 A JP 2024547297A JP 2025507543 A5 JP2025507543 A5 JP 2025507543A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- disorder
- cycloalkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263313212P | 2022-02-23 | 2022-02-23 | |
| US63/313,212 | 2022-02-23 | ||
| PCT/US2023/063113 WO2023164537A1 (en) | 2022-02-23 | 2023-02-23 | Pyrazolyl compounds as kv7 channel activators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507543A JP2025507543A (ja) | 2025-03-21 |
| JP2025507543A5 true JP2025507543A5 (enExample) | 2025-11-19 |
Family
ID=87766732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547297A Pending JP2025507543A (ja) | 2022-02-23 | 2023-02-23 | Ｋｖ７チャネル活性化剤としてのピラゾリル化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250171430A1 (enExample) |
| EP (1) | EP4482486A4 (enExample) |
| JP (1) | JP2025507543A (enExample) |
| KR (1) | KR20240150500A (enExample) |
| CN (1) | CN118678954A (enExample) |
| AU (1) | AU2023225967A1 (enExample) |
| CA (1) | CA3244850A1 (enExample) |
| IL (1) | IL314555A (enExample) |
| MX (1) | MX2024010081A (enExample) |
| WO (1) | WO2023164537A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202528310A (zh) * | 2023-09-20 | 2025-07-16 | 美商深蘋果治療股份有限公司 | 經取代胺化合物，組合物及使用方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3098075A (en) * | 1956-02-10 | 1963-07-16 | Ciba Geigy Corp | New pyrazolo-pyrimidines |
| ATE410161T1 (de) * | 2003-05-02 | 2008-10-15 | Elan Pharm Inc | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen |
| ES2351274T3 (es) * | 2007-06-06 | 2011-02-02 | Torrent Pharmaceuticals Ltd | Nuevos compuestos. |
| UA110324C2 (en) * | 2009-07-02 | 2015-12-25 | Genentech Inc | Jak inhibitory compounds based on pyrazolo pyrimidine |
| CN103619171B (zh) * | 2010-11-03 | 2015-11-25 | 陶氏益农公司 | 杀虫组合物和与其相关的方法 |
| US9067894B1 (en) * | 2013-03-07 | 2015-06-30 | Vanderbilt University | Compound, composition, and method of activating GIRK potassium channel and use of same for treating conditions of interest |
| CN107406380B (zh) * | 2015-02-04 | 2020-04-28 | 上海海雁医药科技有限公司 | 杂环取代的n-磺酰基苯甲酰胺衍生物、其制法与医药上的用途 |
| WO2016164703A1 (en) * | 2015-04-09 | 2016-10-13 | Eisai R & D Management Co., Ltd. | Fgfr4 inhibitors |
| EP3558992A4 (en) * | 2016-12-15 | 2020-12-02 | ONO Pharmaceutical Co., Ltd. | TREK CHANNEL ACTIVATOR (K + CHANNELS ASSOCIATED WITH TWIK) |
| CN114127058B (zh) * | 2019-07-04 | 2024-06-25 | 深圳国顺康医药科技有限公司 | 一种杂环化合物、其药物组合物及用途 |
| CN110627725B (zh) * | 2019-10-14 | 2022-10-18 | 遵义医科大学 | 一种4-取代5-二氟甲基-3-硝基-1h-吡唑类化合物及其制备方法与应用 |
| JP2021121582A (ja) * | 2020-01-31 | 2021-08-26 | クミアイ化学工業株式会社 | ５−（ピラゾール−５−イル）安息香酸アミド誘導体及び有害生物防除剤 |
| EP4482487A4 (en) * | 2022-02-23 | 2026-04-15 | Biohaven Therapeutics Ltd | PYRAZOLYL COMPOUNDS USED AS KV7 CHANNEL ACTIVATORS |
| CN118695860A (zh) * | 2022-02-23 | 2024-09-24 | 拜奥海芬治疗学有限公司 | 作为kv7通道激活剂的吡唑基化合物 |
-
2023
- 2023-02-23 WO PCT/US2023/063113 patent/WO2023164537A1/en not_active Ceased
- 2023-02-23 KR KR1020247031499A patent/KR20240150500A/ko active Pending
- 2023-02-23 MX MX2024010081A patent/MX2024010081A/es unknown
- 2023-02-23 US US18/839,860 patent/US20250171430A1/en active Pending
- 2023-02-23 EP EP23760909.4A patent/EP4482486A4/en active Pending
- 2023-02-23 CA CA3244850A patent/CA3244850A1/en active Pending
- 2023-02-23 IL IL314555A patent/IL314555A/en unknown
- 2023-02-23 JP JP2024547297A patent/JP2025507543A/ja active Pending
- 2023-02-23 CN CN202380021420.5A patent/CN118678954A/zh active Pending
- 2023-02-23 AU AU2023225967A patent/AU2023225967A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501630A5 (enExample) | ||
| JP2025501629A5 (enExample) | ||
| JP2021518844A5 (enExample) | ||
| CN101784533B (zh) | 4-苄基氨基喹啉、含有它们的药物组合物和它们在治疗中的用途 | |
| US7067655B2 (en) | Adenosine A2a receptor antagonists | |
| JP4287146B2 (ja) | トリアゾロ［４，５−ｄ］ピリミジン誘導体およびプリン作用性レセプターアンタゴニストとしてのこれらの使用 | |
| RU2008127501A (ru) | Сульфонилзамещенные 1н-индолы в качастве лигандов 5-гидрокситриптаминовых рецепторов | |
| JP2025501141A5 (enExample) | ||
| RU2009147708A (ru) | Производные оксадиазола и их применение в качестве потенцирующих средств метаботропных глутаматных рецепторов-842 | |
| AU2024202496A1 (en) | Kv7 channel activators compositions and methods of use | |
| JP2021105002A5 (enExample) | ||
| JP2010505794A5 (enExample) | ||
| JP2009515949A5 (enExample) | ||
| ME01903B (me) | Hetrociklički sulfonamidi, njihova upotreba i farmaceutski pripravci | |
| NO340744B1 (no) | Pyrimidinforbindelser som serotoninreseptormodulatorer | |
| RU2006101541A (ru) | Производные пиперазина и способ их применения | |
| JP2023523402A (ja) | スピロウレア誘導体 | |
| RU2009136911A (ru) | Соединения, представляющие собой стиролильные производные, для лечения офтальмических заболеваний и расстройств | |
| JP2018065830A (ja) | ヘテロアリール化合物およびそれらの使用方法 | |
| JP2008533087A5 (enExample) | ||
| JP2025507542A5 (enExample) | ||
| JP2022550459A5 (enExample) | ||
| RU2013124827A (ru) | Производные индола и способ их получения | |
| JP2013533878A (ja) | 疼痛を処置するためのプロキネチシン１受容体拮抗薬 | |
| JP2025111422A (ja) | イソクロマニル化合物の塩およびその結晶体、ならびにそれらの製造方法、治療用途および医薬組成物 |